DPD status and fluoropyrimidines-based treatment: high activity matters too

Dihydropyrimidine dehydrogenase (DPD) status is an indicator of a marked risk for toxicity following fluoropyrimidine (FP)-based chemotherapy. This notion is well-established for low DPD status but little is k...

Source: BMC Cancer - May 18, 2020 Category: Cancer & Oncology Authors: Emmanuel Chamorey, Eric Francois, Marie-Christine Etienne, Jean-Marc Ferrero, Frederic Peyrade, Emmanuel Barranger, Alexandre Bozec, R émy Largillier, Ophelie Cassuto, Julien Viotti, Renaud Schiappa and Gérard Milano Tags: Research article Source Type: research